--- title: 'Accounting Manager at BridgeBio Pharma' canonical: 'https://feeny.ai/job/accounting-manager-bridgebio-pharma-san-francisco-90rhhkz245zz' type: 'job' last_seen: '2026-11-04' --- # Accounting Manager at BridgeBio Pharma - **Company:** BridgeBio Pharma - **Location:** San Francisco, CA - **Compensation:** $135k–$165k - **Posted:** 2026-08-07 - **Last confirmed live:** 2026-11-04 - **Apply:** https://job-boards.greenhouse.io/bridgebio/jobs/5205270007 ## Job description Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. Who you are: The Accounting Manager is an integral part of a growing accounting team and is responsible for overseeing the general ledger close process (including fixed assets, leases, G&A accruals, among others). This role combines hands-on technical accounting responsibilities with people leadership and end-to-end process ownership. The position currently reports to the Senior Manager, Accounting and requires close collaboration with various internal business partners and third-party service providers. A successful candidate thrives in a fast-paced, high-growth environment and is proactive, highly organized, results-oriented, and analytical, with strong attention to detail and excellent communication skills. This individual exercises sound judgment, takes ownership of outcomes, and is highly motivated to consistently deliver high-quality results while supporting the growth and scalability of the organizati - Lead monthly and quarterly close processes, ensuring accuracy, completeness, and timeliness for assigned accounts - Review journal entries, account reconciliations, and supporting schedules for assigned accounts - Manage, coach, and lead two or more direct reports to support the Company’s evolving business needs - Own sections of the quarterly and annual SEC filings (10-Q, 10-K), including preparation and review of footnote disclosures - Own complex accounting areas relevant to biotech, including leasing accounting (ASC 842), fixed assets, software capitalization, G&A operating expenses, prepaids and accruals, and taxes - Identify and escalate emerging accounting risks in a timely manner and recommend appropriate accounting positions - Maintain and enhance SOX-compliant internal controls - Coordinate with internal and external auditors and manage audit requests - Manage strategic partnerships with FP&A, Tax, Legal, IT and Operations - Identify control gaps and implement remediation plans - Develop accounting policies, procedures, and documentation - Lead process improvement initiatives to increase efficiency, reduce manual work, and enhance data quality - Provide mentorship and career development opportunities, fostering a culture of excellence and continuous learning ## Requirements - Bachelor’s degree in accounting; CPA preferred - 7+ years of relevant experience, including a combination of Big 4 (or similar) audit experience with SEC-registered clients and industry experience - Biotech industry experience strongly preferred - Experience with ERP and finance systems (e.g., SAP, Oracle, Coupa) - Proficiency in Microsoft Office Word, Excel, and PowerPoint - Proficiency in AI-enabled tools such as ChatGPT, Claude, Microsoft Copilot, and Google Gemin AI Requirements: Foundational Knowledge: Understanding of AI concepts, including machine learning, natural language processing, and data-driven decision-making. Applied Skills: Demonstrated experience using AI tools and platforms (e.g., generative AI, predictive analytics, automation solutions) to solve business problems or improve workflows Problem-Solving with AI: Ability to identify opportunities where AI can add value, evaluate potential risks or limitations, and implement solutions effectively. Behavioral Characteristics: - Strong work ethic with sound judgment and the ability to work independently - Ability to manage high-volume transactions in a fast-paced environment - Results and detail-oriented mindset with continuous improvement focus - Strong organizational and prioritization skills - Excellent written and verbal communication skills - High sense of urgency with the ability to develop practical solutions to complex, time-sensitive issues - High degree of organizational agility and discretion when managing sensitive matters across all levels of the organization - Proven ability to manage multiple workstreams simultaneously while  remaining calm and effective under pressure At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states. Salary $135,000—$165,000 USD As a global company, our comprehensive benefits may vary based on location.  We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return. For BridgeBio Full-Time U.S Based Roles: Financial & Rewards - Market-leading compensation - 401(k) with employer match - Employee Stock Purchase Program (ESPP) - Pre-tax commuter benefits (transit and parking) - Referral bonus for hired candidates - Subsidized lunch and parking on in-office days Health & Well-Being - 100% employer-paid medical, dental, and vision premiums for you and your dependents - Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA) - Fertility & family-forming benefits - Expanded mental health support (therapy and coaching resources) - Hybrid work model with flexibility - Flexible, “take-what-you-need” paid time off and company-paid holidays - Comprehensive paid medical and parental leave to care for yourself and your family Skill Development & Career Paths: - People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility - We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, & BetterUp Coaching - We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities By applying, you acknowledge that BridgeBio will process your personal information as described in our [Global Candidate Privacy Notice](https://bridgebio.com/bridgebio-global-candidate-privacy-notice). ## About BridgeBio Pharma ## Company Overview - **One-liner**: BridgeBio Pharma develops transformative medicines for genetic conditions, using a decentralized hub-and-spoke model to accelerate drug development from early research to commercialization. - **Entity Type**: Public (Nasdaq: BBIO) - **Headquarters**: Palo Alto, California, USA (with hybrid offices in San Francisco, CA) - **Founded**: Not explicitly stated in provided sources; the company references “over the past 10 years” as of 2026, suggesting founding around 2015–2016. - **Founders**: Not publicly available from provided sources. ## Core Business - **Primary industry**: Biotechnology / Genetic disease therapeutics - **Target customers**: Patients living with genetic conditions, healthcare providers, payers, and academic research partners - **Mission**: “To develop transformative medicines for genetic conditions” and “bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.” ## Products & Services BridgeBio’s pipeline includes both approved therapies and investigational candidates across dozens of indications. Key offerings: - **Acoramidis**: Approved for transthyretin amyloidosis (ATTR) – a first-in-class treatment with $8B+ peak year sales potential. - **Infigratinib**: Phase 3 completed for achondroplasia; published in the *New England Journal of Medicine* (2026). - **BBP-418**: Investigational for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9). - **Encaleret**: Investigational for Autosomal Dominant Hypocalcemia Type 1 (ADH1). - **BBP-812**: Investigational for Canavan Disease. - **BridgeBio Oncology Therapeutics (BBOT)**: Subsidiary focused on RAS and PI3Kα-driven cancers. - **GondolaBio**: Subsidiary developing bioavailable small molecule inhibitors for oncology. - **Other programs**: Covering hypochondroplasia, chronic hypoparathyroidism, and more. The company has received **3 FDA approvals** and has over **70+ peer-reviewed publications**. ## Market Standing - **Valuation / Market Cap**: Not explicitly stated in provided data; as a public company, current market cap can be found on financial platforms (e.g., ~$8B based on peak sales potential, but not a direct valuation number). - **Key Metric**: **3 FDA-approved medicines**; **2000+ patients enrolled** in global clinical trials; **6 Phase 3 trials** conducted over the past 10 years. - **Notable Investors / Partners**: Not detailed in provided sources, but the company partners with leading academic institutions to advance early-stage research. - **Growth Signals**: Recent publication of Phase 3 PROPEL 3 trial results in NEJM (June 2026); expansion into oncology via BBOT and GondolaBio; 100% of pipeline is first-in-class or best-in-class; 48 unique disease indications targeted. ## Competitive Advantages - **Hub-and-spoke model**: Decentralized structure where autonomous affiliate teams (spokes) focus on specific conditions, while a central hub provides clinical, regulatory, and commercial expertise. This enables speed, scalability, and risk reduction. - **First-in-class / best-in-class focus**: 100% of pipeline aims to be first or best in class, targeting underserved genetic conditions with clear biological rationale. - **Speed and adaptability**: The model allows rapid pivoting to the most promising opportunities, reducing development timelines compared to traditional biotech. - **Strong scientific foundation**: Over 70 peer-reviewed papers and collaborations with top academic institutions. ## Strategic Focus - **Advance late-stage pipeline**: Prioritize Phase 3 programs (e.g., infigratinib for achondroplasia, acoramidis for ATTR) and seek additional FDA approvals. - **Expand into oncology**: Leverage subsidiaries BBOT and GondolaBio to address RAS/PI3Kα-driven cancers. - **Maintain urgency**: “Every minute counts” – continue to operate with speed and autonomy to bring treatments to patients faster. - **Build on commercial success**: Leverage existing approved products to fund further R&D and expand global reach. ## Why Work Here - **Award-winning culture**: Named **#1 Best Place to Work** by BioSpace (2026, small biotech category) with an **88% employee engagement score** in 2025. - **Flexible work model**: Hybrid policy with offices in San Francisco and Palo Alto, CA; “flexible working model” emphasized. - **Compensation and benefits**: Market-leading pay, comprehensive healthcare, and strong emphasis on growth and internal mobility. - **Impact-driven mission**: Work on transformative treatments for genetic conditions where patient need is urgent – “Impatient for Patients” is a core mantra. - **Values**: Put patients first, let science speak, think independently, speak up, and act with urgency. The culture is described as “high on standards, low on convention.” - **Growth opportunities**: 113 open jobs (as of mid-2026) across functions including clinical, regulatory, manufacturing, commercial, and corporate; talent community available for future roles. ## Sources 1. [bridgebio.com](https://bridgebio.com/) – Home page with pipeline overview and $8B peak sales potential 2. [bridgebio.com/about](https://bridgebio.com/about) – Company description, hub-and-spoke model, and key metrics 3. [bridgebio.com/careers](https://bridgebio.com/careers) – Careers page with awards, culture, and benefits 4. [investor.bridgebio.com](https://investor.bridgebio.com/overview/default.aspx) – Investor relations overview, latest news, and corporate presentation 5. [job-boards.greenhouse.io/bridgebio](http://job-boards.greenhouse.io/bridgebio) – Current job listings (113 roles) and departmental categories ## Other roles at BridgeBio Pharma - [Senior Director, Medical Publications and Scientific Communications](https://feeny.ai/job/senior-director-medical-publications-and-scientific-communications-bridgebio-mn08tjm9zqd1) — United States - [Associate Director, People Operations Leader (Contract)](https://feeny.ai/job/associate-director-people-operations-leader-contract-bridgebio-pharma-san-ek2rdmg8mjwj) — San Francisco, CA - [Associate Director/Director Process Chemistry](https://feeny.ai/job/associate-director-director-process-chemistry-bridgebio-pharma-united-states-13q4kxjthehv) — United States - [Senior Executive Assistant (Field Medical)](https://feeny.ai/job/senior-executive-assistant-field-medical-bridgebio-pharma-united-states-rsyahyk2rb79) — United States - [Therapeutic Sales Specialist - Central (Attruby)](https://feeny.ai/job/therapeutic-sales-specialist-central-attruby-bridgebio-pharma-united-states-x9y5xq7hke6a) — United States - [Therapeutic Sales Specialist - Southeast (Attruby)](https://feeny.ai/job/therapeutic-sales-specialist-southeast-attruby-bridgebio-pharma-united-states-stspx4mhh6wh) — United States - [Therapeutic Sales Specialist - Great Lakes (Attruby)](https://feeny.ai/job/therapeutic-sales-specialist-great-lakes-attruby-bridgebio-pharma-united-states-g99tvebbrwcf) — United States - [Therapeutic Sales Specialist - Mid Atlantic (Attruby)](https://feeny.ai/job/therapeutic-sales-specialist-mid-atlantic-attruby-bridgebio-pharma-united-states-20g1x2frxe63) — United States - [Therapeutic Sales Specialist - Northeast (Attruby)](https://feeny.ai/job/therapeutic-sales-specialist-northeast-attruby-bridgebio-pharma-united-states-d0h3d71ersq2) — United States - [Therapeutic Sales Specialist - West (Attruby)](https://feeny.ai/job/therapeutic-sales-specialist-west-attruby-bridgebio-pharma-united-states-tfs7wra1ps3j) — United States